2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine has been researched along with Leishmaniasis, Visceral in 1 studies
2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine: a selective inhibitor of nitric oxide synthase; structure given in first source
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, G | 1 |
| Kar, S | 1 |
| Basu Ball, W | 1 |
| Ghosh, K | 1 |
| Das, PK | 1 |
1 other study available for 2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine and Leishmaniasis, Visceral
| Article | Year |
|---|---|
The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms.
Topics: Animals; Antibodies, Monoclonal; Cell Line; Enzyme Activation; Immunity; Inflammation Mediators; Iso | 2014 |